Expertise in
5
conditions

Gyung-min M. Park

Ulsan, KR 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
5
conditions
Ulsan, KR 

Overview

Gyung-min Park practices practicing medicine in Ulsan, Republic of Korea.

Park is highly rated in 5 conditions, according to our data. Their clinical expertise encompasses Coronary Heart Disease, Atherosclerosis, Angina, Percutaneous Coronary Intervention (PCI), and Heart Bypass Surgery.

They are actively involved in clinical research, co-authoring 125 peer reviewed articles and participating in 7 clinical trials.

Locations

Ulsan, Republic of Korea
Other Locations
Seoul, Republic of Korea
Pohang, Republic of Korea
Seoul St. Mary's Hospital, Eunpyeong St. Mary's Hospital, St. Vincent's Hospital, Yangsan, Republic of Korea
Daejeon St. Mary's Hospital, Daejeon, Republic of Korea

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

Prospective Evaluation of MyocaRdial PerFUSion ComputEd Tomography Trial: Ischemia-guided Revascularization Using Perfusion Coronary CT vs. Fractional Flow Reserve
Prospective Evaluation of MyocaRdial PerFUSion ComputEd Tomography Trial: Ischemia-guided Revascularization Using Perfusion Coronary CT vs. Fractional Flow Reserve
Enrollment Status: Recruiting
Publish Date: April 05, 2023
Intervention Type: Device
Study Phase: Not Applicable
Evaluation of Effectiveness and Safety of XIENCE Xpedition/Alpine/Sierra in Routine Clinical Practice; A MULTICENTER, PROSPECTIVE OBSERVATIONAL STUDY
Evaluation of Effectiveness and Safety of XIENCE Xpedition/Alpine/Sierra in Routine Clinical Practice; A MULTICENTER, PROSPECTIVE OBSERVATIONAL STUDY
Enrollment Status: Completed
Publish Date: December 29, 2025
Intervention Type: Device
Intravascular Ultrasound Prediction of Myocardial Size and Coronary Computed Tomography-Derived Ischemic Burden for Coronary Lesion
Intravascular Ultrasound Prediction of Myocardial Size and Coronary Computed Tomography-Derived Ischemic Burden for Coronary Lesion
Enrollment Status: Active_not_recruiting
Publish Date: April 09, 2025
Intervention Type: Other
Randomized Comparison of Drug-Coated Balloons for the Treatment of Superficial Femoral and Popliteal Peripheral Artery Disease: Prospective, Multicenter, Randomized, Controlled Trial
Randomized Comparison of Drug-Coated Balloons for the Treatment of Superficial Femoral and Popliteal Peripheral Artery Disease: Prospective, Multicenter, Randomized, Controlled Trial
Enrollment Status: Completed
Publish Date: August 09, 2024
Intervention Type: Device
Study Phase: Not Applicable
Perfusion CT Registry
Perfusion CT Registry
Enrollment Status: Completed
Publish Date: March 22, 2023
Ten-Year Outcomes of PREmier of Randomized Comparison of Sirolimus-Eluting Stent Implantation Versus Coronary Artery Bypass Surgery for Unprotected Left Main Coronary Artery Stenosis: PRE-COMBAT Trial
Ten-Year Outcomes of PREmier of Randomized Comparison of Sirolimus-Eluting Stent Implantation Versus Coronary Artery Bypass Surgery for Unprotected Left Main Coronary Artery Stenosis: PRE-COMBAT Trial
Enrollment Status: Completed
Publish Date: June 18, 2020
Intervention Type: Procedure
Assessment of Coronary Artery Lesion Using Optical Coherence Tomography Versus IntraVascular Ultrasound for BiorEsorbable Vascular Scaffold Implantation
Assessment of Coronary Artery Lesion Using Optical Coherence Tomography Versus IntraVascular Ultrasound for BiorEsorbable Vascular Scaffold Implantation
Enrollment Status: Terminated
Publish Date: September 06, 2018
Intervention Type: Other
Study Phase: Not Applicable
View 6 Less Clinical Trials

125 Total Publications

Impact of renal function on edoxaban antithrombotic therapy in patients with atrial fibrillation and stable coronary artery disease: a prespecified analysis of the EPIC-CAD trial.
Impact of renal function on edoxaban antithrombotic therapy in patients with atrial fibrillation and stable coronary artery disease: a prespecified analysis of the EPIC-CAD trial.
Journal: EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
Published: April 20, 2026

Frequently Asked Questions about Gyung-min M. Park

Is Gyung-min M. Park a top-rated expert for Coronary Heart Disease?

MediFind is an objective health platform that identifies experts based on real-world data. Gyung-min M. Park is classified as an Distinguished expert for Coronary Heart Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Gyung-min M. Park participate in research or clinical trials?

Yes. Gyung-min M. Park has published 125 articles and abstracts on conditions like Coronary Heart Disease. You can view a list of Gyung-min M. Park's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Park's expertise for a condition
ConditionClose
    View All 20 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile